The Transcriptional Regulators TAZ and YAP Direct Transforming Growth Factor β-induced Tumorigenic Phenotypes in Breast Cancer Cells*♦

Background: The TGFβ and Hippo pathways are dysregulated in metastatic breast cancers. Results: TGFβ-induced cues and nuclear TAZ/YAP converge at the transcriptional level to control gene expression important for tumorigenesis. Conclusion: TAZ/YAP are required to promote TGFβ-induced tumorigenic phenotypes in breast cancer cells. Significance: Our study reveals novel cross-talk between the TGFβ pathway and TAZ/YAP in late-stage breast cancers. Uncontrolled transforming growth factor-β (TGFβ) signaling promotes aggressive metastatic properties in late-stage breast cancers. However, how TGFβ-mediated cues are directed to induce tumorigenic events is poorly understood, particularly given that TGFβ has clear tumor suppressing activity in other contexts. Here, we demonstrate that the transcriptional regulators TAZ and YAP (TAZ/YAP), key effectors of the Hippo pathway, are necessary to promote and maintain TGFβ-induced tumorigenic phenotypes in breast cancer cells. Interactions between TAZ/YAP, TGFβ-activated SMAD2/3, and TEAD transcription factors reveal convergent roles for these factors in the nucleus. Genome-wide expression analyses indicate that TAZ/YAP, TEADs, and TGFβ-induced signals coordinate a specific pro-tumorigenic transcriptional program. Importantly, genes cooperatively regulated by TAZ/YAP, TEAD, and TGFβ, such as the novel targets NEGR1 and UCA1, are necessary for maintaining tumorigenic activity in metastatic breast cancer cells. Nuclear TAZ/YAP also cooperate with TGFβ signaling to promote phenotypic and transcriptional changes in nontumorigenic cells to overcome TGFβ-repressive effects. Our work thus identifies cross-talk between nuclear TAZ/YAP and TGFβ signaling in breast cancer cells, revealing novel insight into late-stage disease-driving mechanisms.

[1]  Xu Li,et al.  UCA1, a non‐protein‐coding RNA up‐regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion , 2008, FEBS letters.

[2]  Zhengyu Zha,et al.  The N-terminal Phosphodegron Targets TAZ/WWTR1 Protein for SCFβ-TrCP-dependent Degradation in Response to Phosphatidylinositol 3-Kinase Inhibition* , 2012, The Journal of Biological Chemistry.

[3]  P. Bult,et al.  Nuclear localization of the transcriptional coactivator YAP is associated with invasive lobular breast cancer , 2013, Cellular Oncology.

[4]  L. Andersson,et al.  Analysis of protein interactions in situ by proximity ligation assays. , 2014, Current topics in microbiology and immunology.

[5]  H. Shibuya,et al.  TMEPAI, a transmembrane TGF-beta-inducible protein, sequesters Smad proteins from active participation in TGF-beta signaling. , 2010, Molecular cell.

[6]  R. Kerbel,et al.  Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy. , 2006, Cancer research.

[7]  N. Yang,et al.  TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin , 2012, Cell cycle.

[8]  David M. Thomas,et al.  The Hippo pathway and human cancer , 2013, Nature Reviews Cancer.

[9]  R. Akhurst,et al.  Complexities of TGF-β Targeted Cancer Therapy , 2012, International journal of biological sciences.

[10]  C. Hill,et al.  Tgf-beta superfamily signaling in embryonic development and homeostasis. , 2009, Developmental cell.

[11]  Darrell N. Kotton,et al.  Figure 3 , 2008 .

[12]  Q. Zeng,et al.  A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. , 2008, Cancer research.

[13]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[14]  P. D’Eustachio,et al.  Cloning of neurotrimin defines a new subfamily of differentially expressed neural cell adhesion molecules , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[15]  C. Arteaga,et al.  Blockade of tumor cell transforming growth factor-betas enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy. , 1998, Experimental cell research.

[16]  S. Sa,et al.  The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts , 2001, Molecular pathology : MP.

[17]  A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion , 2012, Breast Cancer Research.

[18]  Janet Rossant,et al.  The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-β-SMAD pathway. , 2010, Developmental cell.

[19]  R. Beroukhim,et al.  Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.

[20]  B. Olson,et al.  Inhibition of Transforming Growth Factor (TGF)- 1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF- Type I Receptor Kinase Activity: SB-431542 , 2002 .

[21]  Wei He,et al.  Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Marissa E. Nolan,et al.  Par6–aPKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control , 2006, Nature Cell Biology.

[23]  M. Yaffe,et al.  TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal , 2008, Nature Cell Biology.

[24]  Jianmin Zhang,et al.  YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway , 2009, Nature Cell Biology.

[25]  Jun O. Liu,et al.  Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. , 2012, Genes & development.

[26]  Janet Rossant,et al.  The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass. , 2009, Developmental cell.

[27]  S. Bicciato,et al.  Role of TAZ as Mediator of Wnt Signaling , 2012, Cell.

[28]  S Miyano,et al.  Open source clustering software. , 2004, Bioinformatics.

[29]  X. Varelas,et al.  Integrating developmental signals: a Hippo in the (path)way , 2012, Oncogene.

[30]  Zhengyu Zha,et al.  The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCFβ-TrCP E3 Ligase* , 2010, The Journal of Biological Chemistry.

[31]  H. Moses,et al.  Induction by transforming growth factor-β1 of epithelial to mesenchymal transition is a rare event in vitro , 2004, Breast Cancer Research.

[32]  R. Elashoff,et al.  Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. , 2001, Cancer research.

[33]  S. Bicciato,et al.  The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells , 2011, Cell.

[34]  M. Koutsilieris,et al.  Osteoblast-derived growth factors enhance adriamycin-cytostasis of MCF-7 human breast cancer cells. , 1998, Anticancer research.

[35]  S. Maekawa,et al.  Characterization of a Novel Rat Brain Glycosylphosphatidylinositol-anchored Protein (Kilon), a Member of the IgLON Cell Adhesion Molecule Family* , 1999, The Journal of Biological Chemistry.

[36]  J. Massagué,et al.  Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15 , 1997, Nature.

[37]  F. Spaltmann,et al.  CEPU-1, a novel immunoglobulin superfamily molecule, is expressed by developing cerebellar Purkinje cells , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[38]  G. Dontu,et al.  In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. , 2003, Genes & development.

[39]  J. Downward,et al.  Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. , 2003, Molecular cell.

[40]  X. Fang,et al.  Lysophosphatidic Acid–Induced p21Waf1 Expression Mediates the Cytostatic Response of Breast and Ovarian Cancer Cells to TGFβ , 2011, Molecular Cancer Research.

[41]  Jiandie D. Lin,et al.  TEAD mediates YAP-dependent gene induction and growth control. , 2008, Genes & development.

[42]  Satoru Miyano,et al.  Open source clustering software , 2004 .

[43]  H. Shibuya,et al.  TMEPAI, a transmembrane TGF-beta-inducible protein, sequesters Smad proteins from active participation in TGF-beta signaling. , 2010, Molecular cell.

[44]  Jeffrey L. Wrana,et al.  TβRI Phosphorylation of Smad2 on Ser465 and Ser467 Is Required for Smad2-Smad4 Complex Formation and Signaling* , 1997, The Journal of Biological Chemistry.

[45]  N. López-Bigas,et al.  Drosophila GAGA factor is required for full activation of the dE2f1-Yki/Sd transcriptional program , 2012, Cell cycle.

[46]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[47]  G. Feldmann,et al.  Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals , 2007, Cell.

[48]  A. Reith,et al.  SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. , 2002, Molecular pharmacology.

[49]  S. Maekawa,et al.  IgLON cell adhesion molecules regulate synaptogenesis in hippocampal neurons , 2009, Cell biochemistry and function.

[50]  Friedrich Buck,et al.  Neurotractin, A Novel Neurite Outgrowth-promoting Ig-like Protein that Interacts with CEPU-1 and LAMP , 1999, The Journal of cell biology.

[51]  J. Massagué,et al.  TGFβ in Cancer , 2008, Cell.

[52]  B. Hann,et al.  TGFβ1 Inhibition Increases the Radiosensitivity of Breast Cancer Cells In Vitro and Promotes Tumor Control by Radiation In Vivo , 2011, Clinical Cancer Research.

[53]  K. Guan,et al.  A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). , 2010, Genes & development.

[54]  D. Pan,et al.  The hippo signaling pathway in development and cancer. , 2010, Developmental cell.

[55]  Zhengyu Zha,et al.  TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal Transition* , 2009, Journal of Biological Chemistry.

[56]  R. Hynes,et al.  The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain , 2012, Proceedings of the National Academy of Sciences.

[57]  M. Yaffe,et al.  TAZ: a novel transcriptional co‐activator regulated by interactions with 14‐3‐3 and PDZ domain proteins , 2000, The EMBO journal.

[58]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[59]  Q. Ou,et al.  Yes-associated protein promotes tumour development in luminal epithelial derived breast cancer. , 2012, European journal of cancer.

[60]  P. Levitt,et al.  The limbic system-associated membrane protein is an Ig superfamily member that mediates selective neuronal growth and axon targeting , 1995, Neuron.

[61]  Zhengyu Zha,et al.  TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo Pathway , 2008, Molecular and Cellular Biology.

[62]  Hidemi Ito,et al.  TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth , 2012, The Journal of experimental medicine.

[63]  J. Massagué,et al.  GS domain mutations that constitutively activate T beta R‐I, the downstream signaling component in the TGF‐beta receptor complex. , 1995, The EMBO journal.

[64]  Brian Bierie,et al.  Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer , 2006, Nature Reviews Cancer.

[65]  Jianmin Zhang,et al.  Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon , 2006, Proceedings of the National Academy of Sciences.

[66]  M. Olivé,et al.  Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization , 1978, In Vitro.

[67]  Takeshi Imamura,et al.  TGF‐β receptor‐mediated signalling through Smad2, Smad3 and Smad4 , 1997 .

[68]  Xiaolong Yang,et al.  Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF. , 2011, Cancer research.

[69]  R. Frey,et al.  TGFβ regulation of mitogen-activated protein kinases in human breast cancer cells , 1997 .

[70]  J. Massagué,et al.  Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[71]  Joungmok Kim,et al.  The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. , 2010, Genes & development.

[72]  Li Li,et al.  Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. , 2007, Genes & development.

[73]  P. Levitt,et al.  A monoclonal antibody to limbic system neurons. , 1984, Science.

[74]  J. Wrana,et al.  Switch enhancers interpret TGF-β and Hippo signaling to control cell fate in human embryonic stem cells. , 2013, Cell reports.

[75]  C. Arteaga,et al.  p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration. , 2002, Journal of cell science.

[76]  R. Mann,et al.  Genome-wide association of Yorkie with chromatin and chromatin-remodeling complexes. , 2013, Cell reports.